REQUEST A DEMO
Total
USD $0.00
Search more companies

Ena Farma Saglik Urunleri Imalat Ve Dis Ticaret A.S. (Turkiye)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Ena Farma Saglik Urunleri Imalat Ve Dis Ticaret Anonim Sirketi Profile Updated: March 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

ena farma pharmaceutical specializes in importing and producing medicinal products with herbal or natural ingredients. The company focuses on pediatri, ENT, dermatology, and internal medicine, aiming to deliver plant-containing products to the Turkish medicine market. ena farma pharmaceutical has developed a portfolio to meet the needs of both internal and external markets, offering original formulations of herbal products.

Headquarters
No:38 A Zumrutevler Mahallesi Basogretmen Caddesi Maltepe
Istanbul; Marmara; Postal Code: 34852

Contact Details: Purchase the Ena Farma Saglik Urunleri Imalat Ve Dis Ticaret A.S. report to view the information.

Website: http://www.enafarma.com.tr

Basic Information
Total Employees:
Purchase the Ena Farma Saglik Urunleri Imalat Ve Dis Ticaret A.S. report to view the information.
Outstanding Shares:
Purchase the Ena Farma Saglik Urunleri Imalat Ve Dis Ticaret A.S. report to view the information.
Incorporation Date:
March 09, 2009
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Ena Farma Saglik Urunleri Imalat Ve Dis Ticaret A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
152.26%
Total operating revenue
152.26%
Operating profit (EBIT)
172.66%
Net Profit (Loss) for the Period
218.64%
Total assets
138.38%
Total equity
222.97%
Operating Profit Margin (ROS)
2.88%
Net Profit Margin
7.73%
Return on Equity (ROE)
-0.93%
Debt to Equity Ratio
-68.29%
Quick Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?